Sailaja Puttagunta - Dec 10, 2021 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Chief Medical Officer
Signature
/s/ Sailaja Puttagunta
Stock symbol
ITRM
Transactions as of
Dec 10, 2021
Transactions value $
$0
Form type
4
Date filed
12/14/2021, 04:00 PM
Previous filing
Dec 13, 2021
Next filing
Dec 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Share Option (Right to Buy) Award $0 +1.8M $0.00 1.8M Dec 10, 2021 Ordinary Shares 1.8M $0.48 Direct F1
transaction ITRM Restricted Share Units Award $0 +500K $0.00 500K Dec 10, 2021 Ordinary Shares 500K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of December 1, 2021 and the remaining 75% will vest in equal monthly installments thereafter until December 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.
F2 Each restricted share unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.
F3 Subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date and the other terms and conditions of the Issuer's 2021 Inducement Equity Incentive Plan, the RSUs shall vest over four years with 25% of the RSUs vesting on each one-year anniversary of December 1, 2021, such that the total number of RSUs shall be fully vested by December 1, 2025.